Āsīb/shināsī-i Darmāngāhī-i Dāmpizishkī (Apr 2021)

Effect of Beta asarone on concentration of TNF-α in a rat model of Alzheimer’s disease

  • Golshid Saki,
  • Akram Eidi,
  • Pejman Mortazavi,
  • Akbar Vahdati,
  • Negar Panahi

DOI
https://doi.org/10.30495/jvcp.2020.670353
Journal volume & issue
Vol. 15, no. 1 (57) بهار
pp. 1 – 12

Abstract

Read online

Beta asarone which is the major component of Acorus tatarinowii Schott, can pass through the blood-brain-barrier and affect the central nervous system. In the present study, effect of beta asarone on TNF-α level was investigated in β-amyloid-induced alzheimeric male rats. The adult male rats were randomly divided into 9 groups of 6: normal control, sham-operated control, β-asarone (12.5, 25 and 50 mg/kg PO, daily for 50 days), alzheimeric control (bilateral intrahippocampal injection of 4 µl of β-amyloid 1-42) and alzheimeric β-asarone receiving (12.5, 25 and 50 mg/kg PO β-asarone daily for 30 days following β-amyloid injection and subsequent doses of beta asarone for 3 weeks). The rats were sacrificed at the end of the experiment and the TNF-α level was measured in brain homogenate. Our results showed that administration of β-asarone (25 and 50 mg/kg) significantly decreased the TNF-α level (p<0.001) in alzheimeric rats. Thus, these results indicate that β-asarone is effective in providing protection against inflammation induced by β-amyloid.

Keywords